IBI321
IBI321 is an antibody inhibitor targeting PD-1 and TIGIT. IBI321 simultaneously blocks the PD-1-PD-L1/PD-L2 and TIGIT-CD155 inhibitory pathways, restoring T/NK cell antitumor function and promoting IL-2 production in primary human T cells. IBI321 can be used in cancer-related research.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
Species Reactivity
Human
Target
PD-1 & TIGIT
Conjugated
Unconjugated
Anwendung
ELISA, FACS, Functional assay
Chemical Information
-
SMILES
[IBI 321]
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)